Management Team
Board of Directors
Scientific Advisory Board
Clinical Advisors
R&D Leaders
Targeted Medicine
Strategic Alliances
Research Ethics
Our History
Omacetaxine mepesuccinate
Quinamed®
Cancer Discovery Program
Drug Discovery & Preclinical Development
Genomic Clinical Development
Financial Reports
Corporate Governance
Presentation Archive
Information Request
2009 Press Releases
2008 Press Releases
2007 Press Releases
2006 Press Releases
Investor Events Calendar
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome
Prostate Cancer
Culture
Current Openings
June 29, 2009
ChemGenex to Seek Voluntary De-listing from NASDAQ and to Restructure Board to Reflect Compliance Needs
June 09, 2009
ChemGenex’s Omacetaxine Kills Leukemic Stem Cells in Human CML Models
June 09, 2009
ChemGenex’s Omacetaxine Shows Activity in Refractory CML
© 2009 ChemGenex Pharmaceuticals |
Terms of Use
built@zoomedia
